Data Bridge Market Research conducted a recent market intelligence study, thoroughly analysing the Adrenocorticotropic Hormone (ACTH) Market. The newly published report employs an appealing layout ...
AUSTIN, Texas — Preoperative identification of patients with silent adrenocorticotrophic hormone-secreting tumors could potentially change the approach to management. A new study aimed to determine ...
OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025
Oxford, United Kingdom – 14 th July 2025 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane ...
More than 70% of patients with Cushing's disease (CD) receiving long-term treatment with mifepristone (Korlym, Corcept Therapeutics) experienced at least a 2-fold elevation in plasma ...
SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel ...
THE response of the adrenal cortex to intensive stimulation with exogenous ACTH provides an excellent guide to the functional status of the adrenal cortex under most circumstances. Tests based on this ...
Background: The association between mesotheliomas and ectopic ACTH secretion has been rarely reported; we present the first case of ectopic ACTH secretion (EAS) associated with a well-differentiated ...
A 47-year-old woman was referred for assessment for Cushing syndrome. The patient’s history included well-controlled type 2 diabetes mellitus, for which she took two hypoglycemic agents orally, and ...
OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025
OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including congenital adrenal hyperplasiaDesigned to resist competition from endogenous ACTH by maximizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results